Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 320-323

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thalidomide "may be a valuable therapeutic option" in patients with severe gastrointestinal bleeding

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

IV propofol may be a new therapy option for patients with treatment-refractory migraine episodes

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Bexarotene in combination with PUVA may be a treatment option in patients with cutaneous T-cell lymphoma refractory to multiple single-agent therapies

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Cyclosporin Microemulsion in Patients with Inflammatory Bowel Disease

By Latteri M.  

Clinical Pharmacokinetics, Vol. 40, Iss. 6, 2001-01 ,pp. : 473-483

Adis International

Access to resources Recommend Favorite